Design Improvements With SONNET 3

NCT06597747 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-12-31

Study results available
· View outcomes & findings →

Summary

Measuring user-reported satisfaction with the latest behind-the-ear (BTE) audio processor model.

Conditions

  • Hearing Loss, Sensorineural

Interventions

DEVICE

Audio processor

MED-EL SONNET 3 (EAS) audio processor

Sponsors & Collaborators

  • Med-El Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-16
Primary Completion
2025-05-22
Completion
2025-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06597747 on ClinicalTrials.gov